Consistent with enhanced VEGF expression, Bay60-6583-treated mice exhibited higher vessel density than control mice, as assessed by staining melanoma tissue sections for endothelial marker CD31 and VEGF (Figure 2B). Here, VEGFA is linked to melanoma.